Carfilzomib, Daratumumab, and Dexamethasone (kdd) Vs. Lenalidomide-Sparing Pomalidomide-Containing Triplet Regimens for Relapsed/refractory Multiple Myeloma: an Indirect Treatment Comparison.
LEUKEMIA & LYMPHOMA（2024）
关键词
Carfilzomib,indirect treatment comparison,lenalidomide-sparing,progression-free survival,relapsed/refractory multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要